Sinclair Pharma (SPH)

 

SPH Share PerformanceMore

52 week high36.125 20/03/17
52 week low20.500 06/02/18
52 week change -9.500 (-30.16%)
4 week volume8,326,165 26/01/18
price22.000
price date1519228423
close22.450

Latest NewsMore

Broker Forecast - Peel Hunt issues a broker note on Sinclair IS Pharma PLC

Peel Hunt today reaffirms its buy investment rating on Sinclair IS Pharma PLC (LON:SPH) and cut its price target to 48p ...

Director Deals - Sinclair IS Pharma PLC (SPH)

Jeff Thompson, Non Executive Director, bought 200,000 shares in the company on the 16th January 2018 at a price of 23.10...

Director/PDMR Shareholding

RNS Number: 0601C Sinclair Pharma PLC 17 January 2018 Sinclair Pharma plc Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them London, 17 January 2018 Sinclair Pharma plc (AIM:SPH.L) ("Sinclair" or the "Group"), the international aesthetics company, was advised on 16 Jan...

Director Deals - Sinclair IS Pharma PLC (SPH)

Christopher Spooner, Chief Executive Officer, bought 200,000 shares in the company on the 16th January 2018 at a price of...

Director/PDMR Shareholding

RNS Number: 0385C Sinclair Pharma PLC 16 January 2018 Sinclair Pharma plc Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them London, 16 January 2018 Sinclair Pharma plc (AIM:SPH.L) ("Sinclair" or the "Group"), the international aesthetics company, was advised on 16 Jan...

Broker Forecast - Numis issues a broker note on Sinclair IS Pharma PLC

Numis today reaffirms its hold investment rating on Sinclair IS Pharma PLC (LON:SPH) and set its price target at 21p.

Sinclair Pharma gets Brazil regulatory nod

Sinclair Pharma said it had received regulatory approval for its Ellans cosmetic product in Brazil. Ellans is a pre-mixed bi...

Ellans? Approved for Sale in Brazil

RNS Number: 9442B Sinclair Pharma PLC 16 January 2018 Ellans Approved for Sale in Brazil Second generation collagen stimulator approved by ANVISA Launch anticipated within weeks London, 16 January 2018 Sinclair Pharma plc (AIM:SPH.L) ("Sinclair" or the "Group"), the international aesthetics company, is pleased to announce that it has received regulatory...

Fundamental DataMore

EPS-5.9
Dividend yield0 %

Latest discussion posts More

  • Director buys

    Nice to see the CEO, his missus and a non exec put some more skin in the game by buying 200K each. CEO now has about 2% of the company. This on the back of a pretty decent ...
    17-Jan-2018
    charlus
  • CE registration

    RNS: 19/10/2017: New CE mark granted for Silhouette Soft?. Probably what has prompted the move up as people realise that the product has a globally recognised status as an EU ...
    23-Oct-2017
    PharmaD
  • Re: Interims

    Pretty much what the trading update said in July. It didn't impress the markets then as judged by the drift downwards.
    19-Sep-2017
    Red Ninja

Users' HoldingsMore

Users who hold Sinclair Pharma also hold..

Codes & Symbols

ISINGB0033856740
SymbolsSPH, LSE:SPH, SPH.L, SPH:LN, LON:SPH, XLON:SPH

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account